Considering that CADASIL-related NOTCH3 mutations are more frequent in the general population than anticipated (~1 carrier in 400 people), the effect of these NOTCH3 mutations on CH development should be considered. The gene discussed is NOTCH3; the disease is cyclic hematopoiesis.